Report Detail

Request for Sample of this report

Medical Devices & Consumables Global On-body Injectors Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4668375
    • |
  • 22 January, 2026
    • |
  • Global
    • |
  • 106 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global On-body Injectors market size was valued at US$ 213 million in 2025 and is forecast to a readjusted size of US$ 600 million by 2032 with a CAGR of 16.2% during review period.
On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies. The scope of this report is non-insulin On-body injectors.
In 2024, the global sales ofnon-insulin on-body injectorsreached approximately5 million units, with an average market price of$35 per unit.
North America is currently the largest market for on-body injectors, driven by high healthcare spending, early adoption of advanced drug delivery technologies, and a strong presence of key players such as Amgen (with its Neulasta® Onpro® kit). The United States leads in the development and approval of wearable drug delivery systems, especially for chronic conditions like cancer and autoimmune diseases. Growing demand for home-based treatment and reduced hospital visits post-COVID-19 has further accelerated market expansion.
Europe is a strong and steadily growing market for on-body injectors, supported by rising prevalence of chronic diseases, aging populations, and robust healthcare infrastructure. Countries such as Germany, the UK, and France are key adopters, with regulatory support for patient-centric drug delivery systems. The focus on reducing hospital burden and improving patient compliance is encouraging healthcare providers to adopt wearable injectors, particularly for biologics and long-term therapies.
Asia-Pacific is the fastest-growing region for on-body injectors, driven by increasing healthcare awareness, expanding middle-class populations, and rising chronic disease incidence. Countries like China, Japan, and South Korea are investing heavily in digital health and self-administered therapies.
This report is a detailed and comprehensive analysis for global On-body Injectors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global On-body Injectors market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global On-body Injectors market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global On-body Injectors market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global On-body Injectors market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for On-body Injectors
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global On-body Injectors market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include West Pharmaceutical Services, Insulet, Gerresheimer, United Therapeutics, CC Bio, BD, Ypsomed, Enable Injections, Nemera, Stevanato Group, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
On-body Injectors market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Electronic Injectors
Mechanical Injectors
Market segment by Application
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others
Major players covered
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)
MicroMED
Altek Medical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe On-body Injectors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of On-body Injectors, with price, sales quantity, revenue, and global market share of On-body Injectors from 2021 to 2026.
Chapter 3, the On-body Injectors competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the On-body Injectors breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and On-body Injectors market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of On-body Injectors.
Chapter 14 and 15, to describe On-body Injectors sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global On-body Injectors Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Electronic Injectors
    • 1.3.3 Mechanical Injectors
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global On-body Injectors Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Immuno-oncology
    • 1.4.3 Cardiovascular Diseases
    • 1.4.4 Neurological Diseases
    • 1.4.5 Others
  • 1.5 Global On-body Injectors Market Size & Forecast
    • 1.5.1 Global On-body Injectors Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global On-body Injectors Sales Quantity (2021-2032)
    • 1.5.3 Global On-body Injectors Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 West Pharmaceutical Services
    • 2.1.1 West Pharmaceutical Services Details
    • 2.1.2 West Pharmaceutical Services Major Business
    • 2.1.3 West Pharmaceutical Services On-body Injectors Product and Services
    • 2.1.4 West Pharmaceutical Services On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 West Pharmaceutical Services Recent Developments/Updates
  • 2.2 Insulet
    • 2.2.1 Insulet Details
    • 2.2.2 Insulet Major Business
    • 2.2.3 Insulet On-body Injectors Product and Services
    • 2.2.4 Insulet On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Insulet Recent Developments/Updates
  • 2.3 Gerresheimer
    • 2.3.1 Gerresheimer Details
    • 2.3.2 Gerresheimer Major Business
    • 2.3.3 Gerresheimer On-body Injectors Product and Services
    • 2.3.4 Gerresheimer On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Gerresheimer Recent Developments/Updates
  • 2.4 United Therapeutics
    • 2.4.1 United Therapeutics Details
    • 2.4.2 United Therapeutics Major Business
    • 2.4.3 United Therapeutics On-body Injectors Product and Services
    • 2.4.4 United Therapeutics On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 United Therapeutics Recent Developments/Updates
  • 2.5 CC Bio
    • 2.5.1 CC Bio Details
    • 2.5.2 CC Bio Major Business
    • 2.5.3 CC Bio On-body Injectors Product and Services
    • 2.5.4 CC Bio On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 CC Bio Recent Developments/Updates
  • 2.6 BD
    • 2.6.1 BD Details
    • 2.6.2 BD Major Business
    • 2.6.3 BD On-body Injectors Product and Services
    • 2.6.4 BD On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 BD Recent Developments/Updates
  • 2.7 Ypsomed
    • 2.7.1 Ypsomed Details
    • 2.7.2 Ypsomed Major Business
    • 2.7.3 Ypsomed On-body Injectors Product and Services
    • 2.7.4 Ypsomed On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Ypsomed Recent Developments/Updates
  • 2.8 Enable Injections
    • 2.8.1 Enable Injections Details
    • 2.8.2 Enable Injections Major Business
    • 2.8.3 Enable Injections On-body Injectors Product and Services
    • 2.8.4 Enable Injections On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Enable Injections Recent Developments/Updates
  • 2.9 Nemera
    • 2.9.1 Nemera Details
    • 2.9.2 Nemera Major Business
    • 2.9.3 Nemera On-body Injectors Product and Services
    • 2.9.4 Nemera On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Nemera Recent Developments/Updates
  • 2.10 Stevanato Group
    • 2.10.1 Stevanato Group Details
    • 2.10.2 Stevanato Group Major Business
    • 2.10.3 Stevanato Group On-body Injectors Product and Services
    • 2.10.4 Stevanato Group On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Stevanato Group Recent Developments/Updates
  • 2.11 Sonceboz
    • 2.11.1 Sonceboz Details
    • 2.11.2 Sonceboz Major Business
    • 2.11.3 Sonceboz On-body Injectors Product and Services
    • 2.11.4 Sonceboz On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Sonceboz Recent Developments/Updates
  • 2.12 Lohmann Therapie-Systeme
    • 2.12.1 Lohmann Therapie-Systeme Details
    • 2.12.2 Lohmann Therapie-Systeme Major Business
    • 2.12.3 Lohmann Therapie-Systeme On-body Injectors Product and Services
    • 2.12.4 Lohmann Therapie-Systeme On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Lohmann Therapie-Systeme Recent Developments/Updates
  • 2.13 Elcam Drug Delivery Devices (E3D)
    • 2.13.1 Elcam Drug Delivery Devices (E3D) Details
    • 2.13.2 Elcam Drug Delivery Devices (E3D) Major Business
    • 2.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Product and Services
    • 2.13.4 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Elcam Drug Delivery Devices (E3D) Recent Developments/Updates
  • 2.14 MicroMED
    • 2.14.1 MicroMED Details
    • 2.14.2 MicroMED Major Business
    • 2.14.3 MicroMED On-body Injectors Product and Services
    • 2.14.4 MicroMED On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 MicroMED Recent Developments/Updates
  • 2.15 Altek Medical
    • 2.15.1 Altek Medical Details
    • 2.15.2 Altek Medical Major Business
    • 2.15.3 Altek Medical On-body Injectors Product and Services
    • 2.15.4 Altek Medical On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 Altek Medical Recent Developments/Updates

3 Competitive Environment: On-body Injectors by Manufacturer

  • 3.1 Global On-body Injectors Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global On-body Injectors Revenue by Manufacturer (2021-2026)
  • 3.3 Global On-body Injectors Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of On-body Injectors by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 On-body Injectors Manufacturer Market Share in 2025
    • 3.4.3 Top 6 On-body Injectors Manufacturer Market Share in 2025
  • 3.5 On-body Injectors Market: Overall Company Footprint Analysis
    • 3.5.1 On-body Injectors Market: Region Footprint
    • 3.5.2 On-body Injectors Market: Company Product Type Footprint
    • 3.5.3 On-body Injectors Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global On-body Injectors Market Size by Region
    • 4.1.1 Global On-body Injectors Sales Quantity by Region (2021-2032)
    • 4.1.2 Global On-body Injectors Consumption Value by Region (2021-2032)
    • 4.1.3 Global On-body Injectors Average Price by Region (2021-2032)
  • 4.2 North America On-body Injectors Consumption Value (2021-2032)
  • 4.3 Europe On-body Injectors Consumption Value (2021-2032)
  • 4.4 Asia-Pacific On-body Injectors Consumption Value (2021-2032)
  • 4.5 South America On-body Injectors Consumption Value (2021-2032)
  • 4.6 Middle East & Africa On-body Injectors Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global On-body Injectors Sales Quantity by Type (2021-2032)
  • 5.2 Global On-body Injectors Consumption Value by Type (2021-2032)
  • 5.3 Global On-body Injectors Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global On-body Injectors Sales Quantity by Application (2021-2032)
  • 6.2 Global On-body Injectors Consumption Value by Application (2021-2032)
  • 6.3 Global On-body Injectors Average Price by Application (2021-2032)

7 North America

  • 7.1 North America On-body Injectors Sales Quantity by Type (2021-2032)
  • 7.2 North America On-body Injectors Sales Quantity by Application (2021-2032)
  • 7.3 North America On-body Injectors Market Size by Country
    • 7.3.1 North America On-body Injectors Sales Quantity by Country (2021-2032)
    • 7.3.2 North America On-body Injectors Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe On-body Injectors Sales Quantity by Type (2021-2032)
  • 8.2 Europe On-body Injectors Sales Quantity by Application (2021-2032)
  • 8.3 Europe On-body Injectors Market Size by Country
    • 8.3.1 Europe On-body Injectors Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe On-body Injectors Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific On-body Injectors Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific On-body Injectors Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific On-body Injectors Market Size by Region
    • 9.3.1 Asia-Pacific On-body Injectors Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific On-body Injectors Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America On-body Injectors Sales Quantity by Type (2021-2032)
  • 10.2 South America On-body Injectors Sales Quantity by Application (2021-2032)
  • 10.3 South America On-body Injectors Market Size by Country
    • 10.3.1 South America On-body Injectors Sales Quantity by Country (2021-2032)
    • 10.3.2 South America On-body Injectors Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa On-body Injectors Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa On-body Injectors Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa On-body Injectors Market Size by Country
    • 11.3.1 Middle East & Africa On-body Injectors Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa On-body Injectors Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 On-body Injectors Market Drivers
  • 12.2 On-body Injectors Market Restraints
  • 12.3 On-body Injectors Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of On-body Injectors and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of On-body Injectors
  • 13.3 On-body Injectors Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 On-body Injectors Typical Distributors
  • 14.3 On-body Injectors Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on On-body Injectors. Industry analysis & Market Report on On-body Injectors is a syndicated market report, published as Global On-body Injectors Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of On-body Injectors market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo